Trijardy XR

Trijardy XR (empaglifozin/linagliptin/ metformin is a combination of 3 medicines used to treat type 2 diabetes. This medicine lowers blood sugar. Treatment is combined with a balanced diet and exercise. Trijardy XR is more popular than other SGLT2 inhibitor/gliptin/biguanide combinations. There are currently no generic alternatives to Trijardy XR.

GoodRx has partnered with Inside RX and Boehringer Ingelheim Pharmaceuticals to reduce the price for this prescription. Check our savings tips for patient assistance programs and other ways to reduce your cost. Trijardy XR is covered by some Medicare and insurance plans.

Get Trijardy XR for as low as $594.62, which is 21% off the average retail price of $749.29 for the most common version, by using a GoodRx coupon.